115 related articles for article (PubMed ID: 2193225)
1. Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers.
Benz CC; Keniry MA; Ford JM; Townsend AJ; Cox FW; Palayoor S; Matlin SA; Hait WN; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):840-7. PubMed ID: 2193225
[TBL] [Abstract][Full Text] [Related]
2. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
3. The effect of racemic gossypol and at-101 on angiogenic profile of ovcar-3 cells: a preliminary molecular framework for gossypol enantiomers.
Varol U; Karaca B; Tunali D; Degirmenci M; Cirak Y; Purcu DU; Uzunoglu S; Sezgin C; Karabulut B; Sanli UA; Uslu R
Exp Oncol; 2009 Dec; 31(4):220-5. PubMed ID: 20010531
[TBL] [Abstract][Full Text] [Related]
4. The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.
Liu S; Kulp SK; Sugimoto Y; Jiang J; Chang HL; Dowd MK; Wan P; Lin YC
Anticancer Res; 2002; 22(1A):33-8. PubMed ID: 12017312
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
6. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
7. Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies.
Jaroszewski JW; Kaplan O; Cohen JS
Cancer Res; 1990 Nov; 50(21):6936-43. PubMed ID: 2208159
[TBL] [Abstract][Full Text] [Related]
8. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
Moscow JA; Townsend AJ; Cowan KH
Mol Pharmacol; 1989 Jul; 36(1):22-8. PubMed ID: 2747627
[TBL] [Abstract][Full Text] [Related]
9. Identification of constitutive and gamma-interferon- and interleukin 4-regulated proteins in the human renal carcinoma cell line ACHN.
Sullivan CM; Smith DM; Matsui NM; Andrews LE; Clauser KR; Chapeaurouge A; Burlingame AL; Epstein LB
Cancer Res; 1997 Mar; 57(6):1137-43. PubMed ID: 9067284
[TBL] [Abstract][Full Text] [Related]
10. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
[TBL] [Abstract][Full Text] [Related]
11. Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123.
Benz C; Hollander C; Keniry M; James TL; Mitchell M
J Clin Invest; 1987 Feb; 79(2):517-23. PubMed ID: 3805280
[TBL] [Abstract][Full Text] [Related]
12. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
13. Developing gossypol derivatives with enhanced antitumor activity.
Liang XS; Rogers AJ; Webber CL; Ormsby TJ; Tiritan ME; Matlin SA; Benz CC
Invest New Drugs; 1995; 13(3):181-6. PubMed ID: 8729944
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
[TBL] [Abstract][Full Text] [Related]
15. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
16. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide.
Ban N; Takahashi Y; Takayama T; Kura T; Katahira T; Sakamaki S; Niitsu Y
Cancer Res; 1996 Aug; 56(15):3577-82. PubMed ID: 8758929
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
19. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of gossypol cytotoxicity by cyclic AMP in a rat liver cell line.
Hutchinson RW; Barhoumi R; Miles JM; Burghardt RC
Toxicol Appl Pharmacol; 1998 Aug; 151(2):311-8. PubMed ID: 9707507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
